MAP Pharmaceuticals
MAP Pharmaceuticals is focused on developing novel inhalation therapies for respiratory and systemic diseases.
Business Model:
Revenue: $0
Employees: 51-200
Rankings
Industries / Tags:
Detailed MAP Pharmaceuticals Information
MAP Pharmaceuticals was acquired by
Allergan.
The acquisition happend on 2013-01-22.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Mountain View
State: California
Zip:
Country: United States
Financial Info
Stage:
series d
Raised Last:
$50M
Raised Total:$105M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
MAP Pharmaceuticals, Inc., a development stage company, focuses on developing novel inhalation therapies for respiratory and systemic diseases. It has various proprietary product candidates in clinical development, including Unit Dose Budesonide for pediatric asthma in children from six months to eight years of age and MAP0004 for migraine. The company&s;s product portfolio also includes MAP0005 for the treatment of adolescent and adult asthma, and chronic obstructive pulmonary disease; and MAP0001 for the treatment of Type 1 and Type 2 diabetes via pulmonary delivery using its Tempo inhaler. MAP Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Mountain View, California.
Contact Phone:
Contact Email:
MAP Pharmaceuticals went public on 10/5/2007 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/5/2007
Ticker Symbol:
MAPP
IPO Price:
$12/share
Amount Raised:
$60M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2006 | Series C | 4 | $25.2M |
Perseus Real Estate Equities Bay City Capital Skyline Ventures Perseus Real Estate Equities Bay City Capital Skyline Ventures |
9/2004 | Series B | 3 | $30M |
Skyline Ventures Pequot Capital Bay City Capital |
3/2007 | Series D | 6 | $50M |
Skyline Ventures Pequot Capital D. E. Shaw &a; Co. Perseus Brookside Capital Bay City Capital Skyline Ventures Pequot Capital D. E. Shaw &a; Co. Perseus Brookside Capital Bay City Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
